List of insiders holdings for PLUS THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Lim Kian Thiam 10% Owner | 2015-04-20 15:27:05 | 7,400,000 0 | 7,400,000 | Form 4 |
| 2 | OLYMPUS CORP 10% Owner | 2014-09-16 06:01:15 | 3,973,043 0 | 3,973,043 | Form 13D |
| 3 | PostFinance AG 10% Owner | 2018-05-24 16:16:07 | 2,795,561 0 | 2,795,561 | Form 13G |
| 4 | Saad Mark E Chief Financial Officer | 2014-04-15 16:03:45 | 1,228,430 0 | 1,228,430 | Form 4 |
| 5 | SHIRAHAMA NORIO SEIJIRO President - Asia Pacific | 2015-02-03 19:29:24 | 881,159 0 | 881,159 | Form 4 |
| 6 | HEDRICK MARC H Chief Executive Officer | 2026-07-01 16:30:18 | 517,315 0 | 517,315 | Form 4 |
| 7 | COX MARSHALL G Director | 2007-02-28 17:34:31 | 480,000 0 | 480,000 | Form 4 |
| 8 | HENRIKSEN RONALD D Director | 2012-01-04 19:12:26 | 438,592 0 | 438,592 | Form 4 |
| 9 | REUTER BRUCE SVP Sales, Market., Distr. | 2009-02-02 16:55:15 | 394,686 0 | 394,686 | Form 4 |
| 10 | SCHULZKI SHARON Chief Operating Officer | 2005-02-04 19:20:34 | 380,000 0 | 380,000 | Form 4 |
| 11 | Swissquote Bank SA 10% Owner | 2018-08-28 11:11:40 | 376,723 0 | 376,723 | Form 13G |
| 12 | GALETTO CHARLES Sr. Vice President Finance & A | 2006-01-26 16:56:35 | 280,000 0 | 280,000 | Form 4 |
| 13 | Arm Douglas M Sr. VP - Operations | 2009-05-04 20:33:40 | 185,000 0 | 185,000 | Form 4 |
| 14 | SCARBROUGH ELIZABETH Vice President Marketing & Dev | 2006-01-26 17:16:02 | 176,250 0 | 176,250 | Form 4 |
| 15 | FRASER JOHN K Vice President Research & Tech | 2005-02-04 16:46:59 | 166,250 0 | 166,250 | Form 4 |
| 16 | SCOTT MATTHEW Vice President Sales | 2004-06-04 17:46:43 | 165,000 0 | 165,000 | Form 4 |
| 17 | Milstein Alexander M VP - Clinical Development | 2009-02-02 16:57:24 | 155,000 0 | 155,000 | Form 4 |
| 18 | CALHOUN CHRISTOPHER J Chief Executive Officer | 2014-01-14 18:11:01 | 118,125 36,850 | 154,975 | Form 4 |
| 19 | Townsend John Controller | 2015-02-03 19:30:39 | 139,850 0 | 139,850 | Form 4 |
| 20 | Lenk Robert P Director | 2025-08-25 07:30:05 | 139,327 0 | 139,327 | Form 4 |
| 21 | Thompson Tommy G Director | 2016-01-04 17:55:54 | 136,950 0 | 136,950 | Form 4 |
| 22 | Ransom John T VP Research Regn. Cell Techn. | 2007-02-28 18:00:20 | 105,000 0 | 105,000 | Form 4 |
| 23 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | 2026-07-01 16:30:08 | 92,890 0 | 92,890 | Form 4 |
| 24 | Dean Lloyd H Director | 2014-05-20 12:17:05 | 51,059 40,000 | 91,059 | Form 4 |
| 25 | HOLMES E CARMACK Director | 2014-05-20 12:09:12 | 19,517 37,401 | 56,918 | Form 4 |
| 26 | MARTELL RON Director | 2017-01-27 17:46:09 | 50,000 0 | 50,000 | Form 4 |
| 27 | LAPOINTE ANTHONY GREGG Director | 2017-05-24 16:35:45 | 50,000 0 | 50,000 | Form 4 |
| 28 | Jona Ruud J.P. Director | 2014-06-12 16:25:53 | 42,000 0 | 42,000 | Form 4 |
| 29 | Petersen Greg Director | 2025-02-20 17:30:03 | 40,122 0 | 40,122 | Form 4 |
| 30 | Daniels Eric Joseph Chief Development Officer | 2026-04-22 17:00:04 | 40,000 0 | 40,000 | Form 4 |
| 31 | Marino Mark Chief Medical Officer | 2017-03-17 17:10:48 | 31,100 0 | 31,100 | Form 4/A |
| 32 | HAYDEN JEREMY B. General Counsel & VP of BD | 2017-03-17 17:08:19 | 31,100 0 | 31,100 | Form 4/A |
| 33 | HAWRAN PAUL W Director | 2017-01-27 17:48:43 | 25,000 0 | 25,000 | Form 4 |
| 34 | LaFrance Norman D. Chief Medical Officer | 2024-02-26 18:26:31 | 24,073 0 | 24,073 | Form 4 |
| 35 | RICKEY DAVID Director | 2017-11-29 17:40:07 | 10,806 0 | 10,806 | Form 4 |
| 36 | Clowes Howard Director | 2026-07-01 16:30:13 | 4,745 0 | 4,745 | Form 4 |
| 37 | Hawkins Richard J Director | 2026-07-01 16:30:10 | 4,293 0 | 4,293 | Form 4 |
| 38 | KESTEN STEVEN Exec VP and Chief MO | 2016-06-15 18:56:21 | 3,581 400 | 3,981 | Form 4 |
| 39 | ANDREWS RONALD ASBURY Director | 2026-07-01 16:30:21 | 3,686 0 | 3,686 | Form 4 |
| 40 | Guse Kyle Director | 2026-07-01 16:30:21 | 3,686 0 | 3,686 | Form 4 |
| 41 | van Es-Johansson An Director | 2026-07-01 16:30:20 | 3,686 0 | 3,686 | Form 4 |
| 42 | LYONS GARY A Director | 2018-02-09 16:54:03 | 1,801 0 | 1,801 | Form 4 |
| 43 | HARRIS JOHN DAVID VP and GM Cell Therapy | 2017-11-29 17:34:41 | 1,801 0 | 1,801 | Form 4 |
| 44 | Naughton Gail K Director | 2017-11-29 17:39:06 | 1,801 0 | 1,801 | Form 4 |
| 45 | Girao Tiago VP & Chief Financial Officer | 2018-07-27 16:31:45 | 1,051 0 | 1,051 | Form 4 |